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A B S T R A C T
Intraoperative electrocorticography (ECoG) has been in clinical use for many decades, yet the validity of
this procedure in guiding resective surgery for temporal lobe epilepsy (TLE) is still uncertain, especially
in tailored temporal lobectomies in cases of TLE with hippocampal sclerosis.
Methodology: Using a case–control design combined with descriptive and comparative analyses we
retrospectively evaluated two groups of patients: patients (n = 20) who had tailored temporal
lobectomies guided by intraoperative ECoG and patients (n = 19) who had standard temporal
lobectomies without ECoG. Clinical and neuroimaging data, pre- and post-resection ECoG recordings,
and seizure-free outcomes were reviewed.
Results: Of the 20 patients who underwent epilepsy surgery guided by ECoG, pre-resection ECoG studies
found spikes both in mesial temporal lobe (MTL) and lateral temporal lobe (LTL) in 10 patients, and
restricted to the LTL or MTL in 7 and 3 patients respectively. Postsurgical ECoG captured residual
epileptiform activity in only 3 patients, all of whom had MTL and LTL spikes prior to surgery. Postsurgical
follow-up at 16.3 (6.7) months found 15 (75%) patients were seizure free (1A), while 5 (25%) had other
outcomes. Analysis found no difference in the proportion of seizure-free outcomes between patients with
residual epileptiform activity compared to those without residual epileptiform activity, or between patients
who had a tailored resection guided by ECoG and patients who had standard resections without ECoG
monitoring.
Conclusion: The patients who underwent tailored temporal lobe epilepsy surgery guided by ECoG had
similar outcome compared with the patients with epilepsy surgery not guided by ECoG.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The utilization of surgery for focal epilepsy is slowly increasing
because of a greater understanding of the pathophysiology of
surgical treatable epileptic disorders and improved neuroimaging
that can better identify candidates who would beneﬁt from
surgical treatment.1 The number of surgical procedures performed
in the United States increased from approximately 500 in 1985 to
1500 in 1990, and this number has possibly doubled since the last
survey was made. However, these number are still an order of
magnitude below the number of surgical interventions that could
be carried out to address current needs, which estimates place in
the range of 100,000–200,000 potential surgical candidates in the* Corresponding author at: Neurophysiology Department, National Institute of
Neurology, Insurgentes Sur 3877, Col. La Fama, 14269 Tlalpan, Mexico D.F., Mexico.
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1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.04.006United States alone.2 Surgical treatment to abolish seizures is
recommended for certain ‘‘surgically remediable syndromes’’,2,3
including mesial temporal lobe epilepsy (mTLE), which is the most
common form of human focal epilepsy and the most refractory to
pharmacotherapy.4 Mesial TLE is commonly associated with
hippocampal sclerosis (HS). The classical pattern of HS is
characterized by severe loss of principal neurons primarily in
the Sommer sector (CA1 and prosubiculum), CA3, and the hilus of
dentate gyrus with relative sparing of neurons in the CA2 sector
and subiculum, accompanied by astrogliosis and axonal reorgani-
zation.5,6
Surgical resection guided by intraoperative electrocorticogra-
phy (ECoG) has been in clinical use for many decades, although the
utility of this procedure in cases of TLE and HS is still uncertain.7
Medically refractory TLE is currently treated by a variety of surgical
techniques including tailored anterior temporal lobectomy guided
by intraoperative ECoG, standardized anterior temporal lobectomy
with sparing of the lateral temporal neocortex, and amygdalo-
hippocampectomy. Each technique has purported advantages,vier Ltd. All rights reserved.
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three.8 Currently, the use of ECoG in TLE is considered an important
technique in the tailored temporal lobectomy, superﬂuous in
standard anterior temporal lobectomy, and probably unnecessary
in amygdalohippocampectomy.9 However, few papers have been
published on the utility of ECoG in the tailored temporal lobectomy
in patients with neuroimaging evidence for HS.10,11 These studies
have several methodological limitations, including an absence of
post-resection monitoring for residual epileptiform activity, a lack
of homogeneous diagnosis, or preoperative MRI studies.10,11 In the
present case–control study, we reviewed clinical and neuroimag-
ing data, preoperative video-EEG, pre- and post-resection ECoG
recordings, and seizure-free outcomes in two groups of patients:
patients with TLE and HS who had tailored temporal lobectomy
guided by intraoperative ECoG, and a second group that had
standard temporal lobectomy without ECoG. Descriptive and
comparative analyses were carried out on these data to determine
whether there was a greater likelihood for seizure-free outcomes
in patients with tailored resections guided by ECoG with or
without residual epileptiform activity compared to patients who
underwent a standard temporal epilepsy surgery unaided by ECoG
monitoring.
2. Materials and methods
2.1. Patients
During a period of two years from January 2007 through
February 2009 a total of 41 consecutive patients with medically
intractable seizures underwent temporal lobe epilepsy surgery at
National Institute of Neurology, Mexico. Each patient had a
preoperative workup that included laboratory basics, clinical
evaluation, neuroimaging, neuropsychological testing and inter-
ictal and ictal scalp video-EEG monitoring. Of the 41 patients
reviewed for this study, two patients were excluded for incomplete
medical information and follow up. Of the remaining 39 patients,
20 patients underwent tailored temporal lobectomy guided by
ECoG, while 19 patients underwent standard temporal lobectomy
unaided by intraoperative ECoG monitoring. The use of ECoG
during temporal lobe epilepsy surgery was based on the
availability of the hospital’s human and technical resources to
carry out these intraoperative monitoring.
For each patient, seizure semiology was described using the
Clinical and Electroencephalographic Classiﬁcation of Epileptic
Seizure, ILAE 1981.12 Based on preoperative results, all patients in
the present study were diagnosed with unilateral mTLE with
neuroimaging evidence of HS without other lesions. This study was
approved by the local scientiﬁc and bioethical committees at
National Institute of Neurology, Mexico.
2.2. Epilepsy surgery with intraoperative ECoG recordings
Routine unilateral sub-dural ECoG was recorded using a 64-
channel digital EEG monitoring system (EBNeuro S.a.P, Florence,
Italy) and Brain Explorer ampliﬁer. Signals were bandpass ﬁltered
between 0.03 and 70 Hz, sensitivity set to 50 mV/s, and notch ﬁlter
set at 60 Hz. Each recording was carried out using a grid electrode
array (6  4 contacts with 1 cm spacing, IntegraTM Cedex, France)
positioned over the lateral and mesial temporal lobe surfaces. A
reference electrode was placed on the mastoid ipsilateral to the
surgical ﬁeld. Surgical anesthetics were documented and regularly
stopped 10 min before each ECoG recording that lasted 15 min or
longer for each study. Pre-resection ECoG was considered
satisfactory if epileptiform activity was observed and there was
no evidence for burst-suppression. After amygdalo-hippocam-
pectomy, the grid was replaced to the pre-resection location,which was starting position for the ﬁrst post-resection ECoG
recording. Subsequent post-resection recordings were carried after
the grid was repositioned laterally in 1 cm increments over
neocortical temporal lobe areas, and stopped when epileptiform
activity over the temporal lobe was completely or nearly
eliminated.
2.3. Surgery
All the patients were operated by the same neurosurgeon with
special training in epilepsy surgery, using a T2 or T3 trans-
temporal approach. Temporal lobe epilepsy surgery guided by
ECoG consisted of unilateral amygdalo-hippocampectomy that
included microsurgical excision of the head of the anterior body of
hippocampus, amygdale, portions of the uncus and parahippo-
campal gyrus, and followed by the tailored temporal neocortex
resection. Intraoperative recordings described in the preceding
section guided each step of the neurosurgical resection of the
mesial temporal structures and temporal neocortex resulting in a
different extension, shape, or volume of the neocortical resection
in each patient. The comparative surgical group unaided by ECoG
recordings consisted of a standard amygdalo-hippocampectomy
and temporal neocortical resection.
2.4. Neuroimaging and ECoG analysis
Pre-operative high-resolution 3.0 Tesla MRI (T1, T2, and FLAIR
acquisitions) was qualitatively reviewed using a standardized
protocol by two neuroradiologists who were blinded to video-EEG
ﬁndings.
All the ECoG recordings were carried out by a single board
certiﬁed clinical neurophysiologist and were analyzed indepen-
dently by a second neurophysiologist who was blinded to the
outcomes of the patients. We used the terminology and deﬁnitions
of spike and sharp waves from the Committee on Terminology of
the International Federation of Societies for EEG and Clinical
Neurophysiology.13 We did not use any drug to induce epilepti-
form activity during the ECoG recordings. The ECoG results were
classiﬁed using criteria from a previous study,14 and based on pre-
resection ECoG ﬁndings, patients were divided into the following
subgroups: (1) spikes restricted to the mesial temporal lobe (MTL);
(2) spikes both in MTL and lateral temporal lobe (LTL); and (3)
spikes restricted to the LTL.14 Post-resection ECoG was reported
with or without epileptiform activity at the conclusion of the
neurosurgical procedure.
2.5. Post-surgical follow-up
All the patients were followed on an outpatient basis in the
epilepsy clinic at 3, 6, 12, 18 and 24 months after surgery. Seizure
control was reported using the Engel Classiﬁcation,2,4,15 and any
postsurgical complications were recorded at each follow-up visit.
2.6. Statistical analysis
We used descriptive and inferential statistical analysis. All the
variables were analyzed with Fisher’s exact test. A p value was
considered signiﬁcant as <0.05.
3. Results
3.1. Patients with tailored epilepsy surgery guided by ECoG
Twenty patients (6 men, 14 women) between the ages of 23 and
47 years (median 36.9 years) were analyzed. The mean duration of
epilepsy was 29.9 years (9.9 years). Table 1 lists the results of
Table 1
Clinical characteristics and outcome of patients withmesial temporal lobe epilepsy and hippocampal sclerosis that underwent tailored temporal lobe epilepsywith electrocorticography (n=20) compared to patients that underwent
standard temporal lobectomy without electrocorticography (n=19).
No. of
patient
Age
(years)
Sex Handed Type of
seizure11
Epilepsy
diagnosis
(years)
MR ﬁndings (HS) Video-EEG ECoG pre-resection
(localization)
ECoG post
-resection
(residual
epileptiform
activity)
Engel
classiﬁcation
Follow-up
(mo)
Sites
involved
Side
affected
Interictal Ictal
Patients with tailored temporal lobe resection guided by ECoG
1 42 F R SPS, CPS 39 Unilateral R R Temp Ant R Temp Ant LTL IIA 21
2 39 M L CPS 30 Unilateral R R and L Temp Post R Temp Ant LTL & MTL IA 21
3 42 M R CPS 39 Unilateral R R Temp Ant R Temp Ant LTL IA 12
4 34 F R SPS, CPS 21 Unilateral L R and L Temp Ant L Temp Post MTL IIIA 29
5 23 F R SPS, CPS sc TCGS 15 Unilateral L R Temp Ant L Temp Ant LTL & MTL IA 12
6 32 F R CPS 30 Unilateral L L Temp Post L Temp Post LTL & MTL IA 20
7 31 M R CPS sec TCGS 31 Unilateral R R Fronto-temporal R Temporal LTL IB 16
8 43 F R CPS 24 Unilateral R R Temp Ant R Temp Ant LTL & MTL IA 17
9 40 F R SPS 35 Unilateral R R Temp Ant R Temp Ant LTL IA 21
10 32 M R CPS 7 Unilateral R R Temp Ant R Temp Ant MTL IA 16
11 45 F R CPS sec TCGS 37 Unilateral L L Temp Post L Temp Post LTL IA 14
12 37 M R SPS sec TCGS 7 Unilateral R R Temp Ant R Temp Ant LTL & MTL IA 24
13 47 M R CPS sec TCGS 30 Unilateral L L Temp Post L Temp Post LTL & MTL IA 18
14 30 F R CPS, SPS sec TCGS 27 Unilateral R R Temp Ant R Temp Ant LTL IA 12
15 29 F R CPS, CPS sec TCGS 15 Unilateral R R Temp Ant R Temp Ant LTL & MTL + IA 13
16 35 F R CPS, SPS sec TCGS 34 Unilateral R R Temp Post R Temp Post LTL & MTL IIB 12
17 44 F R SPS sec TCGS 41 Bilateral L>R L Temp Post L Temp Post LTL & MTL + IB 12
18 29 F R SPS, CPS, CPS sec TCGS 26 Bilateral R> L R Temp Ant R Temp Ant MTL IA 12
19 45 F R CPS sec TCGS 25 Unilateral L L Temp Post L Temp Post LTL IA 12
20 40 F R CPS sec TCGS 26 Unilateral R R and L Temp Ant R Temp Ant LTL & MTL + IA 12
Patients with standard temporal lobe resection unaided by ECoG
1 36 F R CPS 20 Unilateral R R Temp Ant R Temp Ant IA 18
2 45 F R CPS 44 Unilateral R R Temp Ant R Temp Ant IA 12
3 51 F R CPS, SPS 7 Unilateral L L Temp Post L Fronto-temporal IIA 24
4 32 F R CPS 18 Unilateral R R and L Temp Post R Temp Ant IIA 18
5 32 F R CPS, TCGS 18 Unilateral R R Fronto-temporal R Temp Ant IA 18
6 42 M R SPS, CPS 20 Unilateral L L Temp Post L Temp Post IA 12
7 43 M R CPS sec TCGS 37 Unilateral R R Temp Ant R Temp Ant IA 24
8 28 F R CPS 8 Unilateral L L Temp Post L Temp Post IA 24
9 28 F R SPS, CPS sec TCGS 15 Unilateral R R Fronto-temporal R Temp Ant IIB 12
10 28 F R SPS, CPS 21 Unilateral L L Temp Post L Temp Post IA 12
11 45 F R SPS, CPS 24 Unilateral R R Fronto-temporal R Temp Ant IA 18
12 42 F R CPS sec TCGS 30 Unilateral L L Temp Post L Temp Post IA 24
13 34 F R CPS 29 Unilateral L L Temp Post L Temp Post IA 24
14 16 F R CPS sec TCGS 10 Unilateral R R Fronto-temporal R Temp Ant IA 24
15 35 M R CPS sec TCGS 17 Unilateral L L Fronto-temporal L Temp Post IA 24
16 23 M R SPS, CPC 19 Unilateral L L Temp Post L Temp Post IA 18
17 19 M R CPS 3 Unilateral R R Temp Post R Temp Ant IB 24
18 38 F R CPS 20 Unilateral L L Temp Post L Temp Post IA 18
19 27 M R CPS 24 Unilateral R R Temp Ant R Temp Ant IA 18
R: right; L: left; HS: hippocampal sclerosis; F: female; M:male. Temp Post: temporal posterior; Temp Ant: temporal anterior. LTL: lateral temporal lobe; MTL: mesial temporal lobe; CPS: complex partial seizures; SPS: simple partial
seizures; Sec: secondary; TCGS: tonic–clonic generalized seizures.
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Table 2
Anesthetics used during the ECoG recording of 20 patients that underwent tailored temporal lobe resection.
No. of patient Fentanyl Remifentanil Sufentanil Propofol Lidocaine Isoﬂurane Sevoﬂurane Desﬂurane Midazolam
1 + +
2 + + +
3 + + +
4 + +
5 + +
6 + +
7 + +
8 + + +
9 + +
10 + +
11 + +
12 + +
13 + +
14 + +
15 + +
16 + +
17 + +
18 + +
19 + +
20 + +
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respect to the video-EEG ﬁndings 17 of the 20 (85%) patients had
unilateral interictal that was concordant with temporal lobe of ictal
onset, while the remaining patients had bilateral temporal lobe
interictal spikes. In the 17 patients, 9 (52%) had discharges that began
mainly from right anterior temporal lobe areas.
Table 2 provides a list of anesthetics used prior to the start of
ECoG recordings. Fentanyl in combination with other anesthetics,
such as Propofol, was used in 13 of the 20 (65%) surgical cases.
Review of ECoG data showed pre-resection spikes both in MTL and
LTL in 10 (50%) patients, restricted to the LTL in 7 (35%) patients,
and limited to MTL in only 3 (15%) patients. Inspection of post-
resection ECoG recordings found no evidence of epileptiform
activity in 17 patients (85%), while residual epileptiform abnor-
malities were seen in 3 (15%) patients. Of these latter patients, two
had epileptiform activity on electrode contacts positioned over the
posterior lateral border of resected temporal lobe, while the
remaining patient had residual epileptiform activity over the right
frontal gyrus (Table 1).
Relatively few patients had residual epileptiform activity after
resection, which precluded a formal statistical comparison of
clinical variables listed in Table 1 between patients with and
without remaining spiking activity. However, there was no
indication for differences in epilepsy duration, seizure type, or
sites of ictal onset between the 3 patients with and 17 patients
without residual epileptiform activity.
3.2. Postsurgical outcome and follow-up
The mean distance of posterior temporal resection from the
polar region was 5  1.0 cm. Resections on the right side extended a
distance of 5.2 cm, while those performed on the left side were 4.5 cm
in length. Histopathological evaluation revealed HS in all the cases,
and one patient had HS plus cortical temporal dysplasia type IIB.
Postsurgical follow-up ranged from 12 to 29 months (mean,
16.3 months). Fifteen (75%) patients were seizure free (IA), two
(10%) patients only had auras (IB), two patients (10%) had rare
seizures (IIA and IIB), and only one patient had IIIA outcome. Two
patients developed vascular complications during their hospitali-
zation. The ﬁrst patient had a right thalamic stroke and the second
suffered a cerebellar hemorrhage associated with permanent
neurological deﬁcits.
There was no obvious difference in the mean resection length
between patients that were seizure-free compared to those thatwere not seizure-free. In relation to presence or absence of post-
resection epileptiform activity, there was no difference in the
proportion of seizure-free outcomes between cases with residual
epileptiform activity compared to cases without post-resection
spiking activity (x2 = 2.48, d.f. = 4, p = 0.65).
3.3. Patients with standard temporal lobe epilepsy surgery without
ECoG
Nineteen patients (6 men, 13 women) between the ages of 16
and 51 years (median 33.8 years) were reviewed. The mean
duration of epilepsy was 20 years (10 years). All the patients had
complex partial seizures, either as the sole seizure type (n = 8 or 42%),
or with the addition of either simple partial seizures (n = 6 or 31%) or
with secondary generalized tonic–clonic seizures (n = 5 or 26%).
Review of video-EEG studies revealed with the exception of one
patient who have bilateral temporal lobe interictal spikes, all patients
had unilateral interictal spikes that localized with site of ictal onset.
3.4. Postsurgical outcome and follow-up
All the patients in the second group underwent standard
temporal lobe epilepsy surgery. The mean distance of posterior
temporal resection from the polar region was 4  1.0 cm. In all
patients, histopathologic reports conﬁrmed a diagnosis of HS
indicated on neuroimaging. Following surgery, two patients had
cerebral edema that resolved during their hospitalization without any
permanent neurological deﬁcits.
Postsurgical follow-up ranged from 11 to 24 months (mean, 18
months). Fifteen (79%) patients were seizure free (IA), one (5%)
patient had auras (IB), and three patients (16%) had rare seizures (2
IIA and 1 IIB). There was no difference in the proportion of seizure-
free outcomes between patients who had standard temporal lobe
resection without ECoG and patients with tailored resection
guided by ECoG (x2 = 1.64, d.f. = 4, p = 0.80).
4. Discussion
The success of epilepsy surgery depends on the accurate
localization and complete removal of the epileptogenic zone, i.e.
brain areas necessary and sufﬁcient for generating spontaneous
epileptic seizures.16,17 However, areas of interictal spiking or the
irritative zone are often wider than the ictal onset zone, which is
the gold standard for localizing the epileptogenic zone.16
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follow up. The ECoG could be an early predictor of the long-term
result of surgery.18 Recurrence of postoperative seizures could be
due to a variety of reasons and it may differ from patient to patient.
Incomplete resection of the epileptogenic zone is believed to be the
single most common cause.19
For the last ﬁve decades, intraoperative ECoG has been used to
(1) localize the irritative zone, (2) map cortical functions, and (3) to
predict the success of surgery for epilepsy. Despite its common use,
only a few studies have been done to prove its effectiveness in
these areas,20 and several questions about the role of ECoG in
epilepsy surgery remain unanswered. About 80–84% of epilepsy
surgery centers around the world perform ECoG in some or all of
their patients with focal epilepsy,20–22 yet its role in temporal
epilepsy surgery is still unclear.23 In patients with mTLE who
underwent standard non-tailored resections, the occurrence and
frequency of the residual spikes after resection or de novo spikes
on post-resection ECoG was not correlated with postoperative
seizure outcome.24,25 McKhann et al.,8 in a prospective study
comprising 140 consecutive patients who underwent ECoG-guided
surgery for TLE with or without mesial temporal sclerosis (MTS),
found no difference in seizure-free outcomes between patients
who received a larger hippocampal resection (>2.5 cm) than
patients who had smaller resections. Additionally, in both MTS and
non-MTS groups, residual hippocampal (not cortical or parahip-
pocampal) epileptiform activity detected on post-resection ECoG
correlated with worse seizure outcomes, suggesting intraoperative
hippocampal ECoG can predict the required extent of hippocampal
resection in surgery for TLE. When all ECoG-conﬁrmed epilepto-
genic hippocampal tissue is not removed, outcome from medial
TLE surgery is signiﬁcantly worse. Thus, extending hippocampal
resections posteriorly on the basis of the hippocampal ECoG is the
only form of ECoG based tailoring of temporal resection of
demonstrable value,8,23 but could produce new sites of interictal
spike activity through a process of denervation.26 Reactive post-
resection epileptiform activity does not appear to predict
postoperative seizures, unlike residual spikes unchanged by
resection that is associated with greater likelihood for seizure
recurrence.7,26 Other factors that might predict postoperative
seizure outcome could be morphology or rate of epileptiform
discharges, which was not analyzed in the present study. However,
a previous study that analyzed 17 patients with TLE and HS who
underwent cortico-amgdalohipocampectomy found that only
isolated discharges on intraoperative ECoG and temporal pole
blurring on MRI predicted post-surgical seizure-free outcome.27
In our study we tried to eliminate all this temporal residual
spike activity in order to test this hypothesis, and for this reason
our patients had a more extensive neocortical compared to other
studies that typically limit the lateral resection to a minimum 2–
2.5 cm in the dominant side, 3–4 cm in the non-dominant side, and
3 cm to the hippocampus.11 An important aspect of our surgical
approach not included in the present study was a review of
postsurgical psychological reports to determine how the extent of
resection affects cognitive function. Other studies found seizure-
free outcome in selective amygdalohippocampectomy to be
similar to that of standard anteromesial temporal lobectomy,
but there is evidence for better neuropsychological outcome in
selective amygdalohippocampectomy.28 However, it remains
unclear whether a larger mesial resection extent corresponds
with greater likelihood to eliminate seizures or poorer neuropsy-
chological outcome or both.28
In a previous study of 47 patients who underwent antero-
mesial temporal lobectomy regardless of ECoG ﬁndings found that
pre-resection spikes localized to the posterior temporal neocortex
(not resected) were more frequent in patients with seizure
recurrence (64%) than in seizure-free patients (39%). However,this difference was not statistically signiﬁcant.29 In the present
study, 3 patients had residual epileptiform activity in the ECoG,
two of them had spikes in the temporal posterior lateral regions
and 1 patient had a residual frontal spike activity, but 2 of the 3
became seizure-free. Engel et al., in a study of 59 patients subjected
to a standard unilateral anterior temporal lobectomy found a trend
toward worse outcome in patients with predominantly lateral as
opposed to mesial temporal spike foci, even the spikes seen in the
ECoG was not evaluated to predict the outcome.30Wennberg et al.,
compared chronic stereotactic depth electroencephalography and
acute ECoG in 22 patients with complex partial seizures of
temporal lobe origin and found high sensitivity and absolute
speciﬁcity of the ECoG in capturing lateral temporal neocortical
epileptiform activity, suggesting ECOG could have prognostic
value.31 In our subgroup of patients not seizure free that
underwent epilepsy surgery guided by ECoG, the lateral cortex
was affected in 80% of the cases, and indirectly supports the
previous observations; however the small number of patients is a
limit.
In tailored epilepsy surgery, between 40 and 67% of the cases
are associated with a seizure-free outcome,8,11 in spite of the
occurrence of residual spikes, which can be present in up to 72% of
the patients with seizures compared with 47% of patients with no
seizures or aura.32 In our study we did not found any outcome
difference between the patients with or without residual
epileptiform activity in the ECoG group, and importantly, between
patients that had ECoG-guided tailored resection and patients that
underwent a standard temporal lobe epilepsy surgery not guided
by ECoG. However, other studies with larger samples are needed to
conﬁrm these ﬁndings.
Although a favorable seizure-free outcome may be obtained
using selective and non-selective surgical approaches to the
treatment of patients with non-lesional TLE,29 we also suggested
that the uses of the non-selective and tailored neurosurgical
procedures would be better to avoid missing a coexistent dual
pathology, like cortical dysplasia associated to the HS.12 Dual
pathology was found in one of our patients that underwent
epilepsy surgery guided by ECoG, which showed broad areas of
epileptic activity.
Epilepsy surgery can be performed with the patient awake or
under general anesthesia. ECoG monitoring is more difﬁcult under
general anesthesia due to suppression of brain electrical activity,
and it is often necessary to chemically induce epileptiform activity
to aid in the localization of the epileptogenic zone.33 In the present
study, more than 60% of our patients received fentanyl as part of
the anesthetic protocol during the surgery, and while it was not the
goal of our study, a previous study found that fentanyl activates
epileptiform activity in patients with TLE that could possibly assist
in the localization of the epileptogenic focus during surgery.33
Experimental evidence suggests that induction of epileptiform
activity is mediated through opiate activation at multiple receptor
subtypes, including m, s, k, e and d receptors,33,34 or suppression of
the GABAergic neurotransmission.35
5. Conclusions
The patients who underwent temporal lobe epilepsy surgery
guided by ECoG had similar outcome compared with the patients
that underwent a standard neurosurgical approach not guided by
ECoG. Further prospective and randomized studies are needed to
support these ﬁndings.
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